Top

Published in:

01-03-2016 | Clinical Study

The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma

Authors: Eun Jung Lee, Jeong Hoon Kim, Eun Suk Park, Shin Kwang Khang, Young Hyun Cho, Seok Ho Hong, Chang Jin Kim

Published in: Journal of Neuro-Oncology | Issue 1/2016

Abstract

Because of the rarity of intracranial hemangiopericytomas (HPCs), the role of postoperative radiation therapy (PORT) in the management of HPC remains unclear. This study therefore analyzed the effects of PORT on patterns of failure and survival improvement in patients with HPC. Fifty-two patients surgically treated for intracranial HPC at our institution between 1992 and 2013 were retrospectively analyzed. Patterns of failure were subdivided into local recurrence, regional metastasis, and distant metastasis. Multivariate Cox proportional hazards models were used to assess factors prognostic of treatment failure and survival, and a time-dependent Cox proportional hazards models were used to investigate the correlations between patterns of failure and death. Of the 52 patients, 45 (87 %) underwent gross total resection, and 39 (75 %) received PORT. PORT significantly lengthened local control (LC) and overall survival (OS), by 14 and 13 months, respectively, independent of the extent of resection. Patients who did and did not receive PORT had 5 year LC rates of 97 and 44 %, respectively (HR .05, P = .002); and 10 year OS rates of 83 and 25 %, respectively (hazard ratio (HR) .20, P = .008). PORT, however, did not show preventive effects on regional and distant metastases. The main patterns of failure were local recurrence in patients who did not receive PORT and distant metastasis in those who received PORT. Regional metastasis was a main immediate cause of death (P < .001), and tended to occur more frequently and earlier in patients not receiving PORT.

Available only for authorised users

Chan RC, Thompson GB (1984) Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 60:52–60. doi:10.3171/jns.1984.60.1.0052 CrossRefPubMed

Guthrie BL, Ebersold MJ, Scheithauer BW, Shaw EG (1989) Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery 25:514–522CrossRefPubMed

Jaaskelainen J, Servo A, Haltia M, Wahlstrom T, Valtonen S (1985) Intracranial hemangiopericytoma: radiology, surgery, radiotherapy, and outcome in 21 patients. Surg Neurol 23:227–236CrossRefPubMed

Kim JH, Jung HW, Kim YS, Kim CJ, Hwang SK, Paek SH, Kim DG, Kwun BD (2003) Meningeal hemangiopericytomas: long-term outcome and biological behavior. Surg Neurol 59:47–53 discussion 53-44 CrossRefPubMed

Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI, Bruce JN (2014) The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a surveillance, epidemiology, and end results analysis. J Neurosurg 120:300–308. doi:10.3171/2013.10.JNS13113 CrossRefPubMed

Vuorinen V, Sallinen P, Haapasalo H, Visakorpi T, Kallio M, Jaaskelainen J (1996) Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices. Acta Neurochir 138:1399–1408CrossRefPubMed

Staples JJ, Robinson RA, Wen BC, Hussey DH (1990) Hemangiopericytoma—the role of radiotherapy. Int J Radiat Oncol Biol Phys 19:445–451. doi:10.1089/ten.2005.11.985 CrossRefPubMed

Schiariti M, Goetz P, El-Maghraby H, Tailor J, Kitchen N (2011) Hemangiopericytoma: long-term outcome revisited. J Neurosurg 114:747–755. doi:10.3171/2010.6.JNS091660 CrossRefPubMed

Ghia AJ, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD (2013) Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis. Neurosurgery 72:203–209. doi:10.1227/NEU.0b013e31827b9e68 CrossRefPubMed

10.

Stessin AM, Sison C, Nieto J, Raifu M, Li B (2013) The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database. Int J Radiat Oncol Biol Phys 85:784–790. doi:10.1016/j.ijrobp.2012.05.042 CrossRefPubMed

11.

Ghia AJ, Chang EL, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD (2013) Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. Neurosurgery 73:624–630. doi:10.1227/NEU.0000000000000064 discussion 630-621 CrossRefPubMed

12.

Soyuer S, Chang EL, Selek U, McCutcheon IE, Maor MH (2004) Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. Cancer 100:1491–1497. doi:10.1002/cncr.20109 CrossRefPubMed

13.

Giannini C, Rushing E, Hainfellner J (2007) Haemangiopericytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC Press, Lyon

14.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. doi:10.1007/s00401-007-0243-4 PubMedCentralCrossRefPubMed

15.

National cancer institute (2010) Common terminology criteria for adverse events (CTCAE) v.4 data files. http://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed 8 December 2015

16.

Melone AG, D’Elia A, Santoro F, Salvati M, Delfini R, Cantore G, Santoro A (2014) Intracranial hemangiopericytoma—our experience in 30 years: a series of 43 cases and review of the literature. World Neurosurg 81:556–562. doi:10.1016/j.wneu.2013.11.009 CrossRefPubMed

17.

Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT (2012) Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer 118:1628–1636. doi:10.1002/cncr.26411 CrossRefPubMed

18.

Rutkowski MJ, Sughrue ME, Kane AJ, Aranda D, Mills SA, Barani IJ, Parsa AT (2010) Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg 113:333–339. doi:10.3171/2010.3.JNS091882 CrossRefPubMed

19.

Olson C, Yen CP, Schlesinger D, Sheehan J (2010) Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery. J Neurosurg 112:133–139. doi:10.3171/2009.3.JNS0923 CrossRefPubMed

20.

Rutkowski MJ, Bloch O, Jian BJ, Chen C, Sughrue ME, Tihan T, Barani IJ, Berger MS, McDermott MW, Parsa AT (2011) Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci 18:1500–1504. doi:10.1016/j.jocn.2011.04.009 CrossRefPubMed

21.

Ecker RD, Marsh WR, Pollock BE, Kurtkaya-Yapicier O, McClelland R, Scheithauer BW, Buckner JC (2003) Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patients. J Neurosurg 98:1182–1187. doi:10.3171/jns.2003.98.6.1182 CrossRefPubMed

22.

Fountas KN, Kapsalaki E, Kassam M, Feltes CH, Dimopoulos VG, Robinson JS, Smith JR (2006) Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev 29:145–153. doi:10.1007/s10143-005-0001-9 CrossRefPubMed

23.

Damodaran O, Robbins P, Knuckey N, Bynevelt M, Wong G, Lee G (2014) Primary intracranial haemangiopericytoma: comparison of survival outcomes and metastatic potential in WHO grade II and III variants. J Clin Neurosci 21:1310–1314. doi:10.1016/j.jocn.2013.11.026 CrossRefPubMed

24.

Rajaram V, Brat DJ, Perry A (2004) Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. Hum Pathol 35:1413–1418. doi:10.1016/j.humpath.2004.07.017 CrossRefPubMed

25.

Trabelsi S, Mama N, Chourabi M, Mastouri MH, Ladib M, Popov S, Burford A, Mokni M, Tlili K, Krifa H, Jones C, Yacoubi MT, Saad A, Brahim DH (2015) Meningeal hemangiopericytomas and meningomas: a comparative immunohistochemical and genetic study. Asian Pac J Cancer Prev 16:6871–6876CrossRefPubMed

26.

Zhao P, Zhu T, Tang Q, Liu H, Zhu J, Zhang W (2015) Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma. Int J Clin Exp Med 8:3291–3299PubMedCentralPubMed

27.

Perry A, Scheithauer BW, Nascimento AG (1997) The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am J Surg Pathol 21:1354–1360CrossRefPubMed

28.

Alawi F, Stratton D, Freedman PD (2001) Solitary fibrous tumor of the oral soft tissues: a clinicopathologic and immunohistochemical study of 16 cases. Am J Surg Pathol 25:900–910CrossRefPubMed

29.

Chaubal A, Paetau A, Zoltick P, Miettinen M (1994) CD34 immunoreactivity in nervous system tumors. Acta Neuropathol 88:454–458CrossRefPubMed

30.

Bouvier C, Metellus P, de Paula AM, Vasiljevic A, Jouvet A, Guyotat J, Mokhtari K, Varlet P, Dufour H, Figarella-Branger D (2012) Solitary fibrous tumors and hemangiopericytomas of the meninges: overlapping pathological features and common prognostic factors suggest the same spectrum of tumors. Brain Pathol 22:511–521. doi:10.1111/j.1750-3639.2011.00552.x CrossRefPubMed

31.

Macagno N, Figarella-Branger D, Mokthari K, Metellus P, Jouvet A, Vasiljevic A, Loundou A, Bouvier C (2015) Differential diagnosis of meningeal SFT-HPC and meningioma: which immunohistochemical markers should be used. Am J Surg Pathol. doi:10.1097/PAS.0000000000000526

32.

Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M (2013) Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132. doi:10.1038/ng.2522 PubMedCentralCrossRefPubMed

33.

Mohajeri A, Tayebwa J, Collin A, Nilsson J, Magnusson L, von Steyern FV, Brosjo O, Domanski HA, Larsson O, Sciot R, Debiec-Rychter M, Hornick JL, Mandahl N, Nord KH, Mertens F (2013) Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosom Cancer 52:873–886. doi:10.1002/gcc.22083 CrossRefPubMed

34.

Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, Chen CL, Zhang L, Wang R, Su F, Iyer MK, Roychowdhury S, Siddiqui J, Pienta KJ, Kunju LP, Talpaz M, Mosquera JM, Singer S, Schuetze SM, Antonescu CR, Chinnaiyan AM (2013) Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 45:180–185. doi:10.1038/ng.2509 PubMedCentralCrossRefPubMed

35.

Fletcher CDM, Unni KK, Mertens F (2002) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon

36.

Schweizer L, Koelsche C, Sahm F, Piro RM, Capper D, Reuss DE, Pusch S, Habel A, Meyer J, Gock T, Jones DT, Mawrin C, Schittenhelm J, Becker A, Heim S, Simon M, Herold-Mende C, Mechtersheimer G, Paulus W, Konig R, Wiestler OD, Pfister SM, von Deimling A (2013) Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 125:651–658. doi:10.1007/s00401-013-1117-6 CrossRefPubMed

37.

Barthelmess S, Geddert H, Boltze C, Moskalev EA, Bieg M, Sirbu H, Brors B, Wiemann S, Hartmann A, Agaimy A, Haller F (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184:1209–1218. doi:10.1016/j.ajpath.2013.12.016 CrossRefPubMed

38.

Koelsche C, Schweizer L, Renner M, Warth A, Jones DT, Sahm F, Reuss DE, Capper D, Knosel T, Schulz B, Petersen I, Ulrich A, Renker EK, Lehner B, Pfister SM, Schirmacher P, von Deimling A, Mechtersheimer G (2014) Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology 65:613–622. doi:10.1111/his.12431 CrossRefPubMed

Title: The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma
Authors: Eun Jung Lee
Jeong Hoon Kim
Eun Suk Park
Shin Kwang Khang
Young Hyun Cho
Seok Ho Hong
Chang Jin Kim
Publication date: 01-03-2016
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 1/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-015-2030-8

2024 ASCO Annual Meeting

Springer Medicine

The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation

Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial

Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response

Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells

Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood brain tumor

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas